Pfizer, Takeda advance new cancer drugs across the Atlantic – FierceBiotech

The companies were among several winners of positive recommendations from the EMA’s Committee for Medicinal Products for Human Use (CHMP) on Friday, and their nods represent two cases where the FDA has beat its EU counterpart to the punch.